229 related articles for article (PubMed ID: 9326297)
1. 3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra.
Elverfors A; Pileblad E; Lagerkvist S; Bergquist F; Jonason J; Nissbrandt H
J Neurochem; 1997 Oct; 69(4):1684-92. PubMed ID: 9326297
[TBL] [Abstract][Full Text] [Related]
2. Reserpine-insensitive dopamine release in the substantia nigra?
Elverfors A; Nissbrandt H
Brain Res; 1991 Aug; 557(1-2):5-12. PubMed ID: 1720998
[TBL] [Abstract][Full Text] [Related]
3. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
Elverfors A; Nissbrandt H
Neuropharmacology; 1992 Jul; 31(7):661-70. PubMed ID: 1328918
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
[TBL] [Abstract][Full Text] [Related]
5. Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release.
Heeringa MJ; Abercrombie ED
J Neurochem; 1995 Jul; 65(1):192-200. PubMed ID: 7790860
[TBL] [Abstract][Full Text] [Related]
6. Minor effect of tolcapone, a catechol-O-methyltransferase inhibitor, on extracellular dopamine levels modified by amphetamine or pargyline: a microdialysis study in anaesthetized rats.
Tuomainen P; Törnwall M; Männistö PT
Pharmacol Toxicol; 1996 Jun; 78(6):392-6. PubMed ID: 8829199
[TBL] [Abstract][Full Text] [Related]
7. Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra.
Nissbrandt H; Carlsson A
J Neurochem; 1987 Sep; 49(3):959-67. PubMed ID: 3612134
[TBL] [Abstract][Full Text] [Related]
8. Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum.
Arbilla S; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb; 311(1):45-52. PubMed ID: 7366741
[No Abstract] [Full Text] [Related]
9. Microdialysis with radiometric monitoring of L-[β-11C]DOPA to assess dopaminergic metabolism: effect of inhibitors of L-amino acid decarboxylase, monoamine oxidase, and catechol-O-methyltransferase on rat striatal dialysate.
Okada M; Nakao R; Hosoi R; Zhang MR; Fukumura T; Suzuki K; Inoue O
J Cereb Blood Flow Metab; 2011 Jan; 31(1):124-31. PubMed ID: 20407462
[TBL] [Abstract][Full Text] [Related]
10. Does monoamine oxidase inhibition by pargyline increase extracellular dopamine concentrations in the striatum?
Blaha CD; Coury A; Phillips AG
Neuroscience; 1996 Nov; 75(2):543-50. PubMed ID: 8931017
[TBL] [Abstract][Full Text] [Related]
11. Effects of a short period of vitamin E-deficient diet in the turnover of different neurotransmitters in substantia nigra and striatum of the rat.
Castaño A; Herrera AJ; Cano J; Machado A
Neuroscience; 1993 Mar; 53(1):179-85. PubMed ID: 7682297
[TBL] [Abstract][Full Text] [Related]
12. Isoflurane anesthesia induces biphasic effect on dopamine release in the rat striatum.
Adachi YU; Yamada S; Satomoto M; Higuchi H; Watanabe K; Kazama T
Brain Res Bull; 2005 Oct; 67(3):176-81. PubMed ID: 16144652
[TBL] [Abstract][Full Text] [Related]
13. Effect of dopamine agonists and antagonists on DOPA formation in the substantia nigra.
Argiolas A; Melis MR; Fadda F; Serra G; Gessa GL
J Neurochem; 1982 Jan; 38(1):75-9. PubMed ID: 6809898
[TBL] [Abstract][Full Text] [Related]
14. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats.
Robertson GS; Damsma G; Fibiger HC
J Neurosci; 1991 Jul; 11(7):2209-16. PubMed ID: 1712381
[TBL] [Abstract][Full Text] [Related]
15. Influence of R-type (Cav2.3) and t-type (Cav3.1-3.3) antagonists on nigral somatodendritic dopamine release measured by microdialysis.
Bergquist F; Nissbrandt H
Neuroscience; 2003; 120(3):757-64. PubMed ID: 12895515
[TBL] [Abstract][Full Text] [Related]
16. Age effects on monoamine turnover of the rat substantia nigra.
Venero JL; Machado A; Cano J
Brain Res; 1991 Aug; 557(1-2):109-14. PubMed ID: 1747745
[TBL] [Abstract][Full Text] [Related]
17. Phenylalanine in the caudate nucleus of dopamine depleted rats.
Paetsch PR; Greenshaw AJ; Juorio AV
Neurochem Res; 1993 Sep; 18(9):983-7. PubMed ID: 7694165
[TBL] [Abstract][Full Text] [Related]
18. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW
Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927
[TBL] [Abstract][Full Text] [Related]
19. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
Nissbrandt H; Engberg G; Pileblad E
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
[TBL] [Abstract][Full Text] [Related]
20. Lesion-induced reductions in trace amine accumulation: dependence on MAO inhibitor pretreatment.
Nguyen TV; Juorio AV; Greenshaw AJ
Brain Res Bull; 1989 Feb; 22(2):197-200. PubMed ID: 2495844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
